Literature DB >> 31183179

Evidence for surgical resections in oligometastatic lung cancer.

Rafael A S Fernandez1, Rainbow W H Lau1, Jacky Y K Ho1, Peter S Y Yu1, Simon C Y Chow1, Innes Y P Wan1, Calvin S H Ng1.   

Abstract

With the advent of advanced technology in performing diagnostics for lung cancer, an incremental increase in the number of patients with oligometastatic disease is currently being managed with intent to cure. As treatment of selected types of patients with oligometastasis show favourable outcomes, the past notion of managing these patients palliatively is fast becoming extinct. Selection of patients based on established criterion together with surgical metastasectomy combined with multiple ablative techniques with or without systemic chemotherapy offers a reasonable rate of treatment success which provides basis for treating such patient population. As more evidence becomes available to suggest that the oligometastatic state of lung cancer does exist, and are potentially curable, a better understanding of the condition is necessary for clinicians, and surgeons to provide optimal care. In this review we present some of the clinical basis which may cause a paradigm shift in management of patients with oligometastatic lung disease.

Entities:  

Keywords:  Lung cancer; metastases; oligometastases

Year:  2019        PMID: 31183179      PMCID: PMC6535472          DOI: 10.21037/jtd.2019.04.09

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  22 in total

1.  Direct lymphatic connections from the lower lobes of the lung to the abdomen.

Authors:  K K MEYER
Journal:  J Thorac Surg       Date:  1958-06

Review 2.  Management of non-small cell lung cancer with oligometastasis.

Authors:  Liza C Villaruz; Gregory J Kubicek; Mark A Socinski
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

3.  Outcomes of patients with isolated adrenal metastasis from non-small cell lung carcinoma.

Authors:  Dan J Raz; Michael Lanuti; Henning C Gaissert; Cameron D Wright; Douglas J Mathisen; John C Wain
Journal:  Ann Thorac Surg       Date:  2011-09-22       Impact factor: 4.330

Review 4.  Current readings: the most influential and recent studies regarding resection of lung cancer in m1a disease.

Authors:  Pierre Mordant; Caroline Rivera; Antoine Legras; Françoise Le Pimpec Barthes; Marc Riquet
Journal:  Semin Thorac Cardiovasc Surg       Date:  2013

Review 5.  Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.

Authors:  Allison Ashworth; George Rodrigues; Gabriel Boldt; David Palma
Journal:  Lung Cancer       Date:  2013-08-20       Impact factor: 5.705

6.  A randomized trial of surgery in the treatment of single metastases to the brain.

Authors:  R A Patchell; P A Tibbs; J W Walsh; R J Dempsey; Y Maruyama; R J Kryscio; W R Markesbery; J S Macdonald; B Young
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

Review 7.  An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Authors:  Allison B Ashworth; Suresh Senan; David A Palma; Marc Riquet; Yong Chan Ahn; Umberto Ricardi; Maria T Congedo; Daniel R Gomez; Gavin M Wright; Giulio Melloni; Michael T Milano; Claudio V Sole; Tommaso M De Pas; Dennis L Carter; Andrew J Warner; George B Rodrigues
Journal:  Clin Lung Cancer       Date:  2014-05-15       Impact factor: 4.785

Review 8.  Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.

Authors:  Tawee Tanvetyanon; Lary A Robinson; Michael J Schell; Vivian E Strong; Rachna Kapoor; Daniel G Coit; Gerold Bepler
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

9.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.

Authors:  Kyle E Rusthoven; Brian D Kavanagh; Stuart H Burri; Changhu Chen; Higinia Cardenes; Mark A Chidel; Thomas J Pugh; Madeleine Kane; Laurie E Gaspar; Tracey E Schefter
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

Review 10.  Oligometastases and oligo-recurrence: the new era of cancer therapy.

Authors:  Yuzuru Niibe; Kazushige Hayakawa
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019

View more
  2 in total

1.  Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases.

Authors:  Tugce Kutuk; Robert Herrera; Teuta Z Mustafayev; Gorkem Gungor; Gamze Ugurluer; Banu Atalar; Rupesh Kotecha; Matthew D Hall; Muni Rubens; Kathryn E Mittauer; Jessika A Contreras; James McCulloch; Noah S Kalman; Diane Alvarez; Tino Romaguera; Alonso N Gutierrez; Jacklyn Garcia; Adeel Kaiser; Minesh P Mehta; Enis Ozyar; Michael D Chuong
Journal:  Adv Radiat Oncol       Date:  2022-04-25

2.  Thoracoscopic partial lung resection following pneumonectomy: a report of three cases.

Authors:  Hidenori Goto; Mingyon Mun; Shohei Mori; Joji Samejima; Yosuke Matsuura; Masayuki Nakao; Hirohumi Uehara; Ken Nakagawa; Sakae Okumura
Journal:  J Cardiothorac Surg       Date:  2019-11-04       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.